Clinical Trial Update: Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 study evaluating high-dose clopidogrel in patients with coronary artery disease in Japan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Takeshi Morimoto | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED